Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0001439222-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-09 | 2024-01-09 | AGIO | Gheuens Sarah | Chief Medical Off | S - Sale+OE | $22.99 | -1,789 | 27.9K | -6% | -$41.1K |
| D | 2024-01-09 | 2024-01-05 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | +5,000 | 29.7K | +20% | $0 |
| D | 2024-01-09 | 2024-01-05 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-01-09 | S | D | 1,789 | $22.99 | 27,869 | D | — | — | |
| 2 | Common | Common stock | 2024-01-05 | M | A | 5,000 | $0.00 | 29,658 | D | — | — | (F1) Includes 499 shares purchased through the Company's employee stock purchase plan. |
| 3 | Derivative | Performance share units | 2024-01-05 | M | D | 5,000 | $0.00 | 0 | D | — · — to — | 5,000 Common stock | (F3) Each performance share unit represents a contingent right to receive one share of the issuer's common stock. (F4) The PSUs were granted on September 1, 2021. The PSUs vest upon the achievement of a specified clinical milestone. The performance criteria for the specified clinical milestone was determined to have been met on January 5, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |